Tetraphase Pharmaceuticals Inc. (TTPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: September 23, 2016
Pages: 25
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T0097394341EN
Leaflet:

Download PDF Leaflet

Tetraphase Pharmaceuticals Inc. (TTPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Tetraphase Pharmaceuticals Inc. (Tetraphase) is a clinical stage life science company that discovers and develops antibiotic resistance medicines. The company’s products under clinical development include eravacycline, TP-271, and TP-6076. It develops products for the treatment of respiratory diseases caused by bacterial biothreat and antibiotic resistant public health pathogens. Tetraphase’s eravacycline is used for the treatment of multi-drug resistant (MDR) infections which include MDR gram-negative bacteria. The company offers drugs in therapeutic areas of antibiotics, oncology and inflammatory diseases. It also offers research and creation of tetracycline drugs. Tetraphase is headquartered in Watertown, Massachusetts, the US.

Tetraphase Pharmaceuticals Inc. (TTPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Tetraphase Pharma Secures US$45 Million In Series C Round Of Financing
Equity Offering
Tetraphase Pharma Raises USD173 Million in Public Offering of Shares
Tetraphase Pharma Raises USD86.3 Million in Public Offering of Shares
Tetraphase Pharma Completes Underwriters’ Exercise Of Partial Over-Allotment Option Of Public Offering Of Shares For US$49 Million
Tetraphase Pharma Announces That Underwriters' Of Its IPO Exercise Their Over-Allotment Option
Acquisition
Tetraphase Pharma May Sell Itself
Tetraphase Pharmaceuticals Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer 25

LIST OF TABLES

Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Key Facts, 2015
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Deals By Therapy Area, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016
Tetraphase Pharma Secures US$45 Million In Series C Round Of Financing
Tetraphase Pharma Raises USD173 Million in Public Offering of Shares
Tetraphase Pharma Raises USD86.3 Million in Public Offering of Shares
Tetraphase Pharma Completes Underwriters’ Exercise Of Partial Over-Allotment Option Of Public Offering Of Shares For US$49 Million
Tetraphase Pharma Announces That Underwriters' Of Its IPO Exercise Their Over-Allotment Option
Tetraphase Pharma May Sell Itself
Tetraphase Pharmaceuticals Inc., Key Competitors
Tetraphase Pharmaceuticals Inc., Key Employees
Tetraphase Pharmaceuticals Inc., Subsidiaries 24

LIST OF FIGURES

Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Tetraphase Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Skip to top


Ask Your Question

Tetraphase Pharmaceuticals Inc. (TTPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: